Unique alterations in infection-induced immune activation during pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 118, Issue 2, 2011, Pages 145-153

  Witkin, S S ^a   Linhares, I M ^a   Bongiovanni, A M ^a   Herway, C ^a,b   Skupski, D ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK HOSPITAL QUEENS   (United States)

Author keywords

Amniotic fluid; immune regulation; pregnancy; pro inflammatory responses

Indexed keywords

ADENOSINE; ADVANCED GLYCATION END PRODUCT RECEPTOR; GELSOLIN; HISTONE; HYALURONIC ACID; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AMNION FLUID; AMNION FLUID ANALYSIS; CYTOKINE PRODUCTION; DOWN REGULATION; EXOSOME; FETUS DEVELOPMENT; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INFECTION; NEUTROPHIL; PREGNANCY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; REVIEW; TH1 CELL; TH17 CELL; UPREGULATION; UTERUS;

EID: 78650316097     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02773.x     Document Type: Review

References (94)

1. Goncalves LF, Chaiworapongsa T, Romero R,. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002; 8: 3-13.
2. Sherwin C, Fern R,. Acute lipopolysaccharide-mediated injury in neonatal white matter glia: role of TNF-α, IL-1β, and calcium. J Immunol 2005; 175: 155-61.
3. Gerber S, Vial Y, Hohlfeld P, Witkin SS,. Detection of Ureaplasma urealyticum in second trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis 2003; 187: 518-21.
4. Nguyen DP, Gerber S, Hohlfeld P, Sangrine G, Witkin SS,. Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome. J Perinat Med 2004; 32: 323-6.
5. Wenstrom KD, Andrews WW, Bowles NE, Towbin JA, Hauth JC, Goldenberg RL,. Intrauterine viral infection at the time of second trimester genetic amniocentesis. Obstet Gynecol 1998; 92: 420-4.
6. Yoon BH, Romero R, Lim JH, Shim SS, Hong JS, Shim JY, et al. The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol 2003; 189: 919-24.
7. Steel JH, Malatos S, Kennea N, Edwards AD, Miles L, Duggan P, et al. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr Res 2005; 57: 404-11.
8. Onderdonk AN, Delaney ML, DuBois AM, Allred EN, Leviton A,. Detection of bacteria in placental tissues obtained from extremely low gestational age neonates. Am J Obstet Gynecol 2008; 198: 110e1-7.
9. Galask RP, Varner MW, Petzold CR, Wilbur SL,. Bacterial attachment to the chorioamniotic membranes. Am J Obstet Gynecol 1984; 148: 915-28.
10. Schneider DS, Ayres JS,. Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat Rev Immunol 2008; 8: 889-95.
11. Abrahams VM,. Pattern recognition at the maternal-fetal interface. Immunol Invest 2008; 37: 427-47.
12. Yoshio H, Tollin M, Gudmundsson GH, Lagercrantz H, Jornvall H, Marchini G, et al. Antimicrobial peptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res 2003; 53: 211-6.
13. Roos T, Martin TR, Ruzinski JT, Leturcq DJ, Hillier SL, Patton DL, et al. Lipopolysaccharide binding protein and soluble CD14 receptor protein in amniotic fluid and cord blood in patients at term. Am J Obstet Gynecol 1997; 177: 1230-7.
14. Leviton A,. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev Med Child Neurol 1993; 35: 553-8.
15. Levy O,. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7: 379-90.
16. Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, Wang XY, et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 2009; 183: 7150-60.
17. Eijnden SV, Goriely S, De Wit D, Goldman M, Willems F,. Preferential production of the IL-12(p40)/IL-23(p19) heterodimer by dendritic cells from human newborns. Eur J Immunol 2006; 36: 21-6.
18. Levy O, Coughlin M, Cronstein BN, Roy RM, Desai A, Wessels MR,. The adenosine system selectively inhibits TLR-mediated TNF-α production in the human newborn. J Immunol 2006; 177: 1956-66.
19. Angelone DF, Wessels MR, Coughlin M, Suter EE, Valentini P, Kalish LA, et al. Innate immunity of the human newborn is polarized towards a high ratio of IL6/TNF-a production in vitro and in vivo. Pediatr Res 2006; 60: 205-9.
20. La Pine TR, Joyner JL, Augustine KA, Kwak SD, Hill HR,. Defective production of IL-18 and IL-12 by cord blood mononuclear cells influences the T helper-1 interferon Î response to group B streptococci. Pediatr Res 2003; 54: 276-81.
21. Langrish CL, Buddle JC, Thrashere AJ, Goldblatt D,. Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol 2002; 128: 118-23.
22. Hirsch E, Filipovich Y, Mahendroo M,. Signaling via the type 1 IL-1 and TNF receptors is necessary for bacterially induced preterm labor in a murine model. Am J Obstet Gynecol 2006; 194: 1334-40.
23. Oppmann B, Lesley R, Blom B, Timans C, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13: 715-25.
24. Schnurr M, Toy T, Shin A, Wagner M, Cebn J, Maraskovsky E,. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 2005; 105: 1582-9.
25. Ivanov I, Zhou L, Littman D,. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007; 19: 409-17.
26. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Tricnhieri G, et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th2 cells. J Exp Med 1993; 177: 1199-204.
27. Goriely S, Neurath MF, Goldman M,. How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol 2008; 8: 81-6.
28. Bettelli E, Korn T, Kuchroo VK,. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007; 19: 652-7.
29. Vanden Eijnden S, Goriely S, De Witt D, Williams F, Goldman M,. IL-23 upregulates IL-10 and induces IL-17 synthesis by polyclonally activated naîve T cells in humans. Eur J Immunol 2005; 35: 469-75.
30. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA,. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993; 81: 941-8.
31. DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bil EM, Gotsch F, et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS ONE 2008; 3: e3056.
32. Herway C, Bongiovanni AM, Skupski D, Witkin SS,. An interleukin-23 binding protein in mid-trimester amniotic fluid. Am J Reprod Immunol 2009; 62: 308-13.
33. Maymon E, Romero R, Pacora P, Gomez R, Athayde N, Edwin S, et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of membranes, and intrauterine infection. Am J Obstet Gynecol 2000; 183: 94-9.
34. Helmig BR, Romero R, Espinoza J, Chaiworapongsa T, Bujold E, Gomez R, et al. Neutrophil elastase and secretory leukocyte protease inhibitor in prelabor rupture of membranes, parturition and intra-amniotic infection. J Matern Fetal Neonatal Med 2002; 12: 237-46.
35. Romero R, Avila C, Santhanam U, Sehgal PB,. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 1990; 85: 1392-400.
36. Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ,. Preterm labor is induced by intraamniotic infusions of interleukin-1β and tumor necrosis factor-α but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 2006; 195: 1578-89.
37. Sezen D, Bongiovanni AM, Jean-Pierre C, Linhares IM, Skupski D, Witkin SS,. Ex vivo cytokine production by whole mid-trimester amniotic fluid. J Reprod Immunol 2008; 78: 22-7.
38. Jones SA,. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 2005; 175: 3463-8.
39. Schultz C, Rott P, Temming P, Schlenke P, Moller JC, Bucsky P,. Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 2002; 51: 317-22.
40. Nogueira-Silva C, Santos M, Baptista MJ, Moura RS, Correia-Pinto J,. IL-6 is constitutively expressed during lung morphogenesis and enhances fetal lung explant branching. Pediatr Res 2006; 60: 530-6.
41. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, et al. A randomized controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 1995; 154: 5492-9.
42. H1 cells control themselves by producing interleukin-10. Nat Rev Immunol 2007; 7: 425-8.
43. Sadowsky DW, Novy MJ, Witkin SS, Gravett MG,. Dexamethasone or interleukin-10 block interleukin-1β-induced uterine contractions in pregnant rhesus monkeys. Am J Obstet Gynecol 2003; 188: 252-63.
44. Gravett MG, Witkin SS, Haluska GJ, Edwards JL, Cook MJ, Novy MJ,. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994; 171: 1660-7.
45. Romero R, Manouge KR, Mitchell MD, Wu YK, Oyarzun E, Hobbins JC, et al. Infection and labor IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989; 161: 336-41.
46. Mathison JC, Wolfson E, Ulevitch RJ,. Participation of tumor necrosis factor in the mediation of Gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 1988; 81: 1925-37.
47. Bazzoni F, Beutler B, Flier J, Underhill L,. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996; 334: 1717-24.
48. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP,. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999; 17: 331-67.
49. Buckley CA, Rouhani FN, Kaler M, Adamik B, Hawari FL, Levine SJ,. Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch. Am J Physiol Lung Cell Mol Physiol 2005; 288: L1132-8.
50. Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, et al. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 2000; 275: 14608-14.
51. Menon R, Thorsen P, Vogel I, Jacobsson B, Morgan N, Jiang L, et al. Racial disparity in amniotic fluid concentrations of tumor necrosis factor (TNF)-α and soluble TNF receptors in spontaneous preterm birth. Am J Obstet Gynecol 2008; 198: 533e1-10.
52. Kawasaki H, Iwamuro S,. Potential roles of histones in host defense as antimicrobial agents. Infect Disord Drug Targets 2008; 8: 195-205.
53. Gelber SE, Sezen D, Bongiovanni AM, Perni U, Skupski D, Witkin SS,. Histone 2B in mid-trimester amniotic fluid down-regulates lipopolysaccharide- induced tumor necrosis factor alpha production by amniocytes. Reprod Sci 2008; 15 (Suppl): 87A.
54. Kin HS, Cho JH, Park HW, Yoon H, Kim MS, Kim SC,. Endotoxin-neutralizing antimicrobial proteins of the human placenta. J Immunol 2002; 168: 2356-64.
55. Sun HQ, Yamamoto O, Mejillano M, Yin HL,. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem 1999; 47: 33179-82.
56. Bucki R, Georges PC, Espinassous Q, Funaki M, Pastore JJ, Chaby R, et al. Inactivation of endotoxin by human plasma gelsolin. Biochemistry 2005; 44: 9590-7.
57. Sezen D, Bongiovanni AM, Gelber S, Perni U, Hutson JM, Skupski D, et al. Gelsolin down-regulates lipopolysaccharide-induced intraamniotic tumor necrosis factor-a production in the midtrimester of pregnancy. Am J Obstet Gynecol 2009; 200: 191e1-4.
58. Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H, Golenbock D, et al. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent upon Toll-like receptor 4, CD44, and MD-2. J Biol Chem 2007; 282: 18265-75.
59. Schimizzi AL, Massie JB, Murphy M, Perry A, Kim CW, Garfin SR, et al. High-molecular-weight hyaluronan inhibits macrophage proliferation and cytokine release in the early wound of a preclinical postlaminectomy rat model. Spine J 2006; 6: 550-6.
60. Yasuda T,. Hyaluronan inhibits cytokine production by lipopolysaccharide-stimulated U937 macrophages through down-regulation of NF-kappaB via ICAM-1. Inflamm Res 2007; 56: 246-53.
61. Dahl LB, Dahl IM, Borresen AL,. The molecular weight of sodium hyaluronate in amniotic fluid. Biochem Med Metab Biol 1986; 35: 219-26.
62. Sezen D, Perni U, Herway C, Bongiovanni AM, Skupski D, Witkin SS,. Hyaluronan modulates pro-inflammatory immune activity in the mid-trimester amniotic cavity. J Reprod Immunol 2009; 82: 89-93.
63. Hasko G, Cronstein BN,. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004; 25: 33-9.
64. 2 release in mouse peritoneal macrophages. Int Immunopharmacol 2007; 7: 483-90.
65. Perni U, Sezen D, Bongiovanni AM, Linhares IM, Skupski D, Witkin SS,. Endogenous adenosine down-modulates mid-trimester intraamniotic tumor necrosis factor-α production. Am J Reprod Immunol 2009; 62: 232-7.
66. Seong HAS, Lee SE, Kang JH, Romero R, Yoon BH,. The frequency of microbial invasion of the amniotic cavity and histologic chorioamnionitis in women at term with intact membranes in the presence or absence of labor. Am J Obstet Gynecol 2008; 199: 375e1-5.
67. Chavakis T, Bierhaus A, Nawroth PP,. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect 2004; 6: 1219-25. (Pubitemid 39370091)
68. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999; 97: 889-901.
69. Buhimschi IA, Zhao G, Pettker CM, Bahtiyar MO, Maglire LK, Thung S, et al. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol 2007; 196: 181e1-12.
70. Keelan JA, Yang J, Romero RJ, Chaiworapongsa T, Marvin KW, Sato T, et al. Epithelial cell-derived neutrophil-activating peptide-78 in fetal membranes and amniotic fluid at increased concentrations with intra-amniotic infection and preterm delivery. Biol Reprod 2004; 70: 253-9.
71. Espinoza J, Chaiworapongsa T, Romero R, Edwin S, Rathnasabapathy C, Gomez R, et al. Antimicrobial peptides in amniotic fluids: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med 2003; 13: 2-21.
72. Barral AM, von Herrath MG,. Exosomes: specific intercellular nano-shuttles? Curr Immunol Rev 2005; 1: 1-6.
73. Peche H, Heslan M, Usal C, Amigorena S, Cuturi MC,. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 2003; 76: 1503-10.
74. Kravets FG, Lee J, Singh B, Trocchia A, Pentala SM, Khan SA,. Prostasomes: current concepts. Prostate 2000; 43: 169-74.
75. Karlsson M, Lundin S, Dahlgren U, Kahu H, Pettersson I, Telemo E,. 'Tolerosomes' are produced by intestinal epithelial cells. Eur J Immunol 2001; 31: 2892-900.
76. Asea A, Jean-Pierre C, Kaur P, Rao P, Linhares IM, Skupski D, et al. Heat shock protein-containing exosomes in mid-trimester amniotic fluids. J Reprod Immunol 2008; 79: 12-7.
77. Keller S, Rupp C, Stoeck A, Runz S, Fogel M, Lugert S, et al. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int 2007; 72: 1095-102.
78. Taylor DD, Akyol S, Gercel-Taylor C,. Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol 2006; 176: 1534-42.
79. Abrahams VM, Straszewski-Chavez SL, Guller S, Mor G,. First trimester trophoblast cells secrete Fas ligand which induces cell apoptosis. Mol Hum Reprod 2004; 10: 55-63.
80. Frangsmyr L, Baranov V, Nagaeva O, Stendahl U, Kjellberg L, Mincheva-Nilsson L,. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol Hum Reprod 2004; 11: 35-41.
81. Quinjtana FJ, Cohen IR,. Heat shock proteins as endogenous adjuvants in sterile and septic inflammation. J Immunol 2005; 175: 2777-82.
82. Jean-Pierre C, Perni SC, Bongiovanni AM, Kalish RB, Karasahan E, Ravich M, et al. Extracellular 70 kd heat shock protein in mid-trimester amniotic fluid and its effect on cytokine production by ex vivo-cultured amniotic fluid cells. Am J Obstet Gynecol 2006; 194: 694-8.
83. Bangen JM, Schade FU, Flohe SB,. Diverse regulatory activity of human heat shock proteins 60 and 70 on endotoxin-induced inflammation. Biochem Biophys Res Commun 2007; 359: 709-15.
84. Perni SC, Vardhana S, Kalish R, Chasen S, Witkin SS,. Clara cell protein 16 in mid-trimester amniotic fluid: association with fetal gender, fetal GA +38 CC16 gene polymorphism and pregnancy outcome. J Reprod Immunol 2005; 68: 85-90.
85. Kim J-Y, Lee SY, Park S-C, Shin SY, Choi SJ, Park Y, et al. Purification and antimicrobial activity studies of the N-terminal fragment of ubiquitin from human amniotic fluid. Biochim Biophys Acta 2007; 1774: 1221-6.
86. Ghezzi F, Franchi M, Raio L, Di Naro E, Bossi G, Eril GVM, et al. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery. Am J Obstet Gynecol 2002; 186: 268-73.
87. Menon R, Fortunato SJ,. Induction of triggering receptors of myeloid cell (TREM-1) expression in fetal membranes and higher concentrations of soluble TREM-1 in amniotic fluid with spontaneous preterm birth. Reprod Sci 2008; 15: 825-30.
88. Kusanovic JP, Romero R, Chaiworapongsa T, Mittal P, Mazaki-Tovi S, vaisbuch E, et al. Amniotic fluid sTREM-1 in normal pregnancy, spontaneous parturition at term and preterm, and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 2010; 23: 34-47.
89. Dulay AT, Buhimschi CS, Zhao G, Oliver EA, Mbele A, Jing S, et al. Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. J Immunol 2009; 182: 7244-53.
90. Ruetschi U, Rosen A, Karlsson G, Zetterberg H, Rymo L, Hagberg H, et al. Proteomic analysis using chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J Proteome Res 2005; 4: 2236-42.
91. Buhimschi IA, Christner R, Buhimschi CS,. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 2005; 112: 173-81.
92. Gravett MG, Thomas A, Schneider KA, Reddy AP, Dasari S, Jacob T, et al. Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection. J Proteome Res 2007; 6: 89-96.
93. Lyttle B, Chai J, Gonzalez JM, Xu H, Sammel M, Elovitz MA,. The negative regulators of the host immune response: an unexplored pathway in preterm birth. Am J Obstet Gynecol 2009; 201: 284e1-7.
94. Warren HS, Fitting C, Hoff E, Adib-Conquy M, Beasley-Topliffe L, Tesini B, et al. Resilience to bacterial infection: differences between species could be due to proteins in serum. J Infect Dis 2010; 201: 223-32.